keyword
https://read.qxmd.com/read/38647430/identifying-and-assessing-putative-allosteric-sites-and-modulators-for-cxcr4-predicted-through-network-modeling-and-site-identification-by-ligand-competitive-saturation
#1
JOURNAL ARTICLE
Tugce Inan, Robin Flinko, George K Lewis, Alexander D MacKerell, Ozge Kurkcuoglu
The chemokine receptor CXCR4 is a critical target for the treatment of several cancer types and HIV-1 infections. While orthosteric and allosteric modulators have been developed targeting its extracellular or transmembrane regions, the intramembrane region of CXCR4 may also include allosteric binding sites suitable for the development of allosteric drugs. To investigate this, we apply the Gaussian Network Model (GNM) to the monomeric and dimeric forms of CXCR4 to identify residues essential for its local and global motions located in the hinge regions of the protein...
April 22, 2024: Journal of Physical Chemistry. B
https://read.qxmd.com/read/38646783/ubiquitin-driven-g-protein-coupled-receptor-inflammatory-signaling-at-the-endosome
#2
REVIEW
Norton Cheng, Julio M Pimentel, JoAnn Trejo
G protein-coupled receptors (GPCRs) are ubiquitously expressed cell surface receptors that mediate numerous physiological responses and are highly druggable. Upon activation GPCRs rapidly couple to heterotrimeric G proteins and are then phosphorylated and internalized from the cell surface. Recent studies indicate that GPCRs not only localize at the plasma membrane but also exist in intracellular compartments where they are competent to signal. Intracellular signaling by GPCRs is best described to occur at endosomes...
April 22, 2024: American Journal of Physiology. Cell Physiology
https://read.qxmd.com/read/38645173/%C3%AE-arrestin-biased-allosteric-modulator-of-neurotensin-receptor-1-reduces-ethanol-drinking-and-responses-to-ethanol-administration-in-rodents
#3
Graydon B Gereau, Diana Zhou, Kalynn J Van Voorhies, Ryan E Tyler, Jeffrey Campbell, Jackson G Murray, Ali Alvararez-Pamir, Luke Wykoff, Michel A Companion, Michael R Jackson, Steven H Olson, Lawrence S Barak, Lauren M Slosky, Ryan P Vetreno, Joyce Besheer, Zoe A McElligott
Alcohol use disorders (AUDs) impose an enormous societal and financial burden, and world-wide, alcohol misuse is the 7th leading cause of premature death1. Despite this, there are currently only 3 FDA approved pharmacological treatments for the treatment of AUDs in the United States. The neurotensin (Nts) system has long been implicated in modulating behaviors associated with alcohol misuse. Recently, a novel compound, SBI-553, that biases the action of Nts receptor 1 (NTSR1) activation, has shown promise in preclinical models of psychostimulant misuse...
April 13, 2024: bioRxiv
https://read.qxmd.com/read/38643909/comparison-of-the-function-of-two-novel-human-dopamine-d2-receptor-variants-identifies-a-likely-mechanism-for-their-pathogenicity
#4
JOURNAL ARTICLE
Dayana Rodriguez-Contreras, Javier García-Nafría, Amy E Chan, Ujwal Shinde, Kim A Neve
Two recently discovered DRD2 mutations, c.634A > T, p.Ile212Phe and c.1121 T > G, p.Met374Arg, cause hyperkinetic movement disorders that have overlapping features but apparently differ in severity. The two known carriers of the Met374Arg variant had early childhood disease onset and more severe motor, cognitive, and neuropsychiatric deficits than any known carriers of the Ile212Phe variant, whose symptoms were first apparent in adolescence. Here, we evaluated if differences in the function of the two variants in cultured cells could explain differing pathogenicity...
April 19, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38643023/beneath-the-surface-endosomal-gpcr-signaling
#5
REVIEW
Emmanuel Flores-Espinoza, Alex R B Thomsen
G protein-coupled receptors (GPCRs) located at the cell surface bind extracellular ligands and convey intracellular signals via activation of heterotrimeric G proteins. Traditionally, G protein signaling was viewed to occur exclusively at this subcellular region followed by rapid desensitization facilitated by β-arrestin (βarr)-mediated G protein uncoupling and receptor internalization. However, emerging evidence over the past 15 years suggests that these βarr-mediated events do not necessarily terminate receptor signaling and that some GPCRs continue to activate G proteins after having been internalized into endosomes...
April 19, 2024: Trends in Biochemical Sciences
https://read.qxmd.com/read/38639976/constitutive-internalisation-of-ep2-differentially-regulates-g-protein-signalling
#6
JOURNAL ARTICLE
Abigail R Walker, Holly Ann Parkin, Sung Hye Kim, Vasso Terzidou, David F Woodward, Phillip R Bennett, Aylin C Hanyaloglu
The prostanoid G protein-coupled receptor (GPCR) EP2 is widely expressed and implicated in endometriosis, osteoporosis, obesity, pre-term labour, and cancer. Internalisation and intracellular trafficking are critical for shaping GPCR activity, yet little is known regarding spatial programming of EP2 signalling and whether this can be exploited pharmacologically. Using three EP2-selective ligands that favour activation of different EP2 pathways, we show that EP2 undergoes limited agonist-driven internalisation but is constitutively internalised via dynamin-dependent, β-arrestin-independent pathways...
April 1, 2024: Journal of Molecular Endocrinology
https://read.qxmd.com/read/38631405/mapping-the-interaction-site-for-%C3%AE-arrestin-2-in-the-prokineticin-2-receptor
#7
JOURNAL ARTICLE
R Lattanzi, I Casella, M R Fullone, M Vincenzi, D Maftei, R Miele
G protein-coupled receptors (GPCRs) are a family of cell membrane receptors that couple and activate heterotrimeric G proteins and their associated intracellular signalling processes after ligand binding. Although the carboxyl terminal of the receptors is essential for this action, it can also serve as a docking site for regulatory proteins such as the β-arrestins. Prokineticin receptors (PKR1 and PKR2) are a new class of GPCRs that are able to activate different classes of G proteins and form complexes with β-arrestins after activation by the endogenous agonists PK2...
April 15, 2024: Cellular Signalling
https://read.qxmd.com/read/38629290/genetic-deletion-of-%C3%AE-arrestin-2-from-the-subfornical-organ-and-other-periventricular-nuclei-in-the-brain-alters-fluid-homeostasis-and-blood-pressure
#8
JOURNAL ARTICLE
Natalia M Mathieu, Eden E Tan, John J Reho, Daniel T Brozoski, Patricia C Muskus, Ko-Ting Lu, Kelsey K Wackman, Justin L Grobe, Pablo Nakagawa, Curt D Sigmund
BACKGROUND: ANG (angiotensin II) elicits dipsogenic and pressor responses via activation of the canonical Gαq (G-protein component of the AT1 R [angiotensin type 1 receptor])-mediated AT1 R in the subfornical organ. Recently, we demonstrated that ARRB2 (β-arrestin 2) global knockout mice exhibit a higher preference for salt and exacerbated pressor response to deoxycorticosterone acetate salt. However, whether ARRB2 within selective neuroanatomical nuclei alters physiological responses to ANG is unknown...
April 17, 2024: Hypertension
https://read.qxmd.com/read/38621994/-identification-of-1-3-8-triazaspiro-4-5-decane-2-4-dione-derivatives-as-a-novel-delta-opioid-receptor-selective-agonist-chemotype
#9
JOURNAL ARTICLE
Yazan J Meqbil, Jhoan Aguilar, Arryn T Blaine, Lan Chen, Robert J Cassell, Amynah A Pradhan, Richard M van Rijn
Delta opioid receptors hold potential as a target for neurological and psychiatric disorders, yet no delta opioid receptor agonist has proven efficacious in critical phase II clinical trials. The exact reasons for the failure to produce quality drug candidates for the delta opioid receptor is nuclear. However, it is known that certain delta opioid receptor agonists can induce seizures and exhibit tachyphylaxis. Several studies have suggested that those adverse effects are more prevalent in delta agonists that share the SNC80/BW373U86 chemotype...
April 15, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/38621656/an-intracellular-vhh-targeting-the-luteinizing-hormone-receptor-modulates-g-protein-dependent-signaling-and-steroidogenesis
#10
JOURNAL ARTICLE
Camille Gauthier, Pauline Raynaud, Frédéric Jean-Alphonse, Amandine Vallet, Océane Vaugrente, Vinesh Jugnarain, Thomas Boulo, Christophe Gauthier, Eric Reiter, Gilles Bruneau, Pascale Crepieux
Luteinizing hormone (LH) is essential for reproduction, controlling ovulation and steroidogenesis. Its receptor (LHR) recruits various transducers leading to the activation of a complex signaling network. We recently identified iPRC1, the first variable fragment from heavy-chain-only antibody (VHH) interacting with intracellular loop 3 (ICL3) of the follicle-stimulating hormone receptor (FSHR). Because of the high sequence similarity of the human FSHR and LHR (LHCGR), here we examined the ability of the iPRC1 intra-VHH to modulate LHCGR activity...
April 13, 2024: Molecular and Cellular Endocrinology
https://read.qxmd.com/read/38614428/local-anesthetics-inhibit-muscarinic-acetylcholine-receptor-mediated-calcium-responses-and-the-recruitment-of-%C3%AE-arrestin-in-hsy-human-parotid-cells
#11
JOURNAL ARTICLE
Mari Shimatani, Takao Morita, Rezon Yanuar, Akihiro Nezu, Akihiko Tanimura
OBJECTIVES: Local anesthetics act on G protein-coupled receptors (GPCRs); thus, their potential as allosteric modulators of GPCRs has attracted attention. Intracellular signaling via GPCRs involves both G-protein- and β-arrestin-mediated pathways. To determine the effects of local anesthetics on muscarinic acetylcholine receptors (mAChR), a family of GPCRs, we analyzed the effects of local anesthetics on mAChR-mediated Ca2+ responses and formation of receptor-β-arrestin complexes in the HSY human parotid cell line...
April 11, 2024: Journal of Oral Biosciences
https://read.qxmd.com/read/38614227/txnip-knockdown-protects-rats-against-bupivacaine-induced-spinal-neurotoxicity-via-the-inhibition-of-oxidative-stress-and-apoptosis
#12
JOURNAL ARTICLE
Yang Zhao, Yuanyuan Chen, Ziru Liu, Lei Zhou, Jiao Huang, Xi Luo, Yunpeng Luo, Jia Li, Yunan Lin, Jian Lai, Jingchen Liu
Bupivacaine (BUP) is an anesthetic commonly used in clinical practice that when used for spinal anesthesia, might exert neurotoxic effects. Thioredoxin-interacting protein (TXNIP) is a member of the α-arrestin protein superfamily that binds covalently to thioredoxin (TRX) to inhibit its function, leading to increased oxidative stress and activation of apoptosis. The role of TXNIP in BUP-induced oxidative stress and apoptosis remains to be elucidated. In this context, the present study aimed to explore the effects of TXNIP knockdown on BUP-induced oxidative stress and apoptosis in the spinal cord of rats and in PC12 cells through the transfection of adeno-associated virus-TXNIP short hairpin RNA (AAV-TXNIP shRNA) and siRNA-TXNIP, respectively...
April 14, 2024: Free Radical Biology & Medicine
https://read.qxmd.com/read/38613153/differential-contributions-of-g-protein-or-arrestin-subtype-mediated-signalling-underlie-urocortin-3-induced-somatostatin-secretion-in-pancreatic-%C3%AE-cells
#13
JOURNAL ARTICLE
Kai-Yu Wang, Ming-Xin Gao, Hai-Bo Qi, Wen-Tao An, Jing-Yu Lin, Shang-Lei Ning, Fan Yang, Peng Xiao, Jie Cheng, Wei Pan, Qiu-Xia Cheng, Jin Wang, Le Fang, Jin-Peng Sun, Xiao Yu
BACKGROUND AND PURPOSE: Pancreatic islets are modulated by cross-talk among different cell types and paracrine signalling plays important roles in maintaining glucose homeostasis. Urocortin 3 (UCN3) secreted by pancreatic β cells activates the CRF2 receptor (CRF2 R) and downstream pathways mediated by different G protein or arrestin subtypes in δ cells to cause somatostatin (SST) secretion, and constitutes an important feedback circuit for glucose homeostasis. EXPERIMENTAL APPROACH: Here, we used Arrb1-/- , Arrb2-/- , Gsfl/fl and Gqfl/fl knockout mice, the G11 -shRNA-GFPfl/fl lentivirus, as well as functional assays and pharmacological characterization to study how the coupling of Gs , G11 and β-arrestin1 to CRF2 R contributed to UCN3-induced SST secretion in pancreatic δ cells...
April 12, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38608683/heterogeneity-of-tethered-agonist-signaling-in-adhesion-g-protein-coupled-receptors
#14
JOURNAL ARTICLE
Andrew N Dates, Daniel T D Jones, Jeffrey S Smith, Meredith A Skiba, Maria F Rich, Maggie M Burruss, Andrew C Kruse, Stephen C Blacklow
Adhesion G protein-coupled receptor (aGPCR) signaling influences development and homeostasis in a wide range of tissues. In the current model for aGPCR signaling, ligand binding liberates a conserved sequence that acts as an intramolecular, tethered agonist (TA), yet this model has not been evaluated systematically for all aGPCRs. Here, we assessed the TA-dependent activities of all 33 aGPCRs in a suite of transcriptional reporter, G protein activation, and β-arrestin recruitment assays using a new fusion protein platform...
April 4, 2024: Cell Chemical Biology
https://read.qxmd.com/read/38604257/gpcr-kinase-subtype-requirements-for-arrestin-2-and-3-translocation-to-the-type-1-cannabinoid-receptor-and-the-consequences-on-g-protein-signalling
#15
JOURNAL ARTICLE
Jamie J Manning, David B Finlay, Michelle Glass
Arrestins are key negative regulators of G Protein-Coupled Receptors (GPCRs) through mediation of G protein desensitisation and receptor internalisation. Arrestins can also contribute to signal transduction by scaffolding downstream signalling effectors for activation. GPCR kinase (GRK) enzymes phosphorylate the intracellular C-terminal domain, or intracellular loop regions of GPCRs to promote arrestin interaction. There are seven different GRK subtypes, which may uniquely phosphorylate the C-terminal tail in a type of 'phosphorylation barcode,' potentially differentially contributing to arrestin translocation and arrestin-dependent signalling...
April 9, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38600384/ligand-efficacy-modulates-conformational-dynamics-of-the-%C3%A2%C2%B5-opioid-receptor
#16
JOURNAL ARTICLE
Jiawei Zhao, Matthias Elgeti, Evan S O'Brien, Cecília P Sár, Amal Ei Daibani, Jie Heng, Xiaoou Sun, Elizabeth White, Tao Che, Wayne L Hubbell, Brian K Kobilka, Chunlai Chen
The µ-opioid receptor (µOR) is an important target for pain management1 and molecular understanding of drug action on µOR will facilitate the development of better therapeutics. Here we show, using double electron-electron resonance and single-molecule fluorescence resonance energy transfer, how ligand-specific conformational changes of µOR translate into a broad range of intrinsic efficacies at the transducer level. We identify several conformations of the cytoplasmic face of the receptor that interconvert on different timescales, including a pre-activated conformation that is capable of G-protein binding, and a fully activated conformation that markedly reduces GDP affinity within the ternary complex...
April 10, 2024: Nature
https://read.qxmd.com/read/38597712/synthesis-and-functional-evaluation-of-synthetic-cannabinoid-receptor-agonists-related-to-adb-hexinaca
#17
JOURNAL ARTICLE
Eric Sparkes, Axelle Timmerman, Jack W Markham, Rochelle Boyd, Rebecca Gordon, Katelyn A Walker, Richard C Kevin, David E Hibbs, Samuel D Banister, Elizabeth A Cairns, Christophe Stove, Adam Ametovski
ADB-HEXINACA has been recently reported as a synthetic cannabinoid receptor agonist (SCRA), one of the largest classes of new psychoactive substances (NPSs). This compound marks the entry of the n -hexyl tail group into the SCRA landscape, which has continued in the market with recent, newly detected SCRAs. As such, a proactive characterization campaign was undertaken, including the synthesis, characterization, and pharmacological evaluation of ADB-HEXINACA and a library of 41 closely related analogues. Two in vitro functional assays were employed to assess activity at CB1 and CB2 cannabinoid receptors, measuring Gβγ -coupled agonism through a fluorescence-based membrane potential assay (MPA) and β-arrestin 2 (βarr2) recruitment via a live cell-based nanoluciferase complementation reporter assay...
April 10, 2024: ACS Chemical Neuroscience
https://read.qxmd.com/read/38584327/npas2-transcriptionally-activated-by-arrb1-promotes-the-malignant-behaviours-of-lung-adenocarcinoma-cells-and-regulates-the-reprogramming-of-glucose-metabolism
#18
JOURNAL ARTICLE
Shenglan Wang, Chunhong Huang, Yanbin Zheng, Xinjie Wu, Yutong Zhong
Lung adenocarcinoma (LUAD) is a serious threat to public health and is accompanied by increased morbidity and mortality worldwide. Neuronal PAS domain protein2 (NPAS2) has been confirmed as an oncogene in LUAD; however, little is known about its molecular mechanism. Here, the expression level of NPAS2 was detected in LUAD cell lines and 16HBE cells. Gain- and loss-of-function experiments were performed. Cell Counting Kit-8, colony formation, flow cytometry, wound-healing and Transwell assays were conducted to assess cell proliferation, apoptosis, migration and invasion, respectively...
May 2024: Clinical and Experimental Pharmacology & Physiology
https://read.qxmd.com/read/38573544/ehmt2-suppresses-arrb1-transcription-and-activates-the-hedgehog-signaling-to-promote-malignant-phenotype-and-stem-cell-property-in-oral-squamous-cell-carcinoma
#19
JOURNAL ARTICLE
Ling Niu, Guangyao Hu
Oral squamous cell carcinoma (OSCC) represents the primary subtype of head and neck squamous cell carcinoma (HNSCC), characterized by a high morbidity and mortality rate. Although previous studies have established specific correlations between euchromatic histone lysine methyltransferase 2 (EHMT2), a histone lysine methyltransferase, and the malignant phenotype of OSCC cells, its biological functions in OSCC remain largely unknown. This study, grounded in bioinformatics predictions, aims to clarify the influence of EHMT2 on the malignant behavior of OSCC cells and delve into the underlying mechanisms...
April 4, 2024: Molecular Biotechnology
https://read.qxmd.com/read/38573198/chemoattractant-receptor-signaling-in-humoral-immunity
#20
JOURNAL ARTICLE
Taiichiro Shirai, Akiko Nakai, Kazuhiro Suzuki
Efficient induction of humoral immune responses depends on orchestrated migration of B cells within lymphoid organs, which is governed by G protein-coupled receptors (GPCRs) responding to chemoattractants, represented by chemokines. After ligand binding, GPCRs are phosphorylated by different GPCR kinases (GRKs) at distinct sites on the receptor C termini, which dictates functional outcomes of β-arrestin-mediated signaling, ranging from receptor inactivation to effector molecule activation. However, the molecular mechanisms by which individual GRKs are selectively targeted to GPCRs have been poorly understood...
April 4, 2024: International Immunology
keyword
keyword
63997
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.